Position in COLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,249,464
-$5,300,718 QoQ
Shares Held
338,383
-36.2% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 280 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. COLL ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in COLL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,249,464 | 338,383 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,550,182 | 530,698 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,274,365 | 653,874 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,638,227 | 389,775 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,030,061 | 203,925 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,794,790 | 261,132 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,240,342 | 217,813 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,262,861 | 265,602 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,403,388 | 198,863 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,730,964 | 199,149 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,817,923 | 221,505 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,244,147 | 145,152 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,399,294 | 111,647 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,471,233 | 144,695 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $558,516 | 24,074 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $361,475 | 22,564 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $431,800 | 24,368 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,666,426 | 130,964 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,228,617 | 119,305 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $909,599 | 46,079 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||